Cancer Connection
to Mercury, Toxic Metals, Root-Canaled-Teeth, and Dental Cavitations, with information on cancer treatment B.Windham (Ed)
The President’s Cancer Panel Report for
2008-2009 found that the true burden of environmentally induced cancers has
been grossly underestimated (547). Other studies and documentation
have similar findings (560). Toxic metals show evidence of carcinogenic and
estrogenic properties that contribute to cancer (3b,100, etc.). More study evidence supported that mercury can contribute to the
pathogenesis of pancreatic cancer (3a) and other cancers. A number of
observations indicate that heavy metals are able to alter cellular metabolic
pathways through induction of a prooxidative state (3c). It is shown that Hg
(II) elicits a prooxidative state in keratinocytes linked to inhibition of gap
junction-mediated intercellular communication and proinflammatory cytokine
production. These combined effects may on one hand isolate cells from
tissue-specific homeostasis promoting their proliferation and on the other hand
tamper the immune system defense/surveillance checkmating the whole organism. Mercury is an example of a "metagenetic" effector (3c,17).
As seen here, in addition to cancers caused
by radiation, pesticides, and other organic chemicals, toxic metals such as
mercury have major effects on weakening the immune system and facilitating
cancer (17). Studies have documented that most people have significant
accumulation of toxic metals and pesticides and need to test (6) and detox: (Pectasol, chlorella, Berberine, etc.)
Medical labs,
medical studies, and government agencies have documented that dental
amalgam is the largest source of mercury in most people who have several
amalgam fillings (1,500). Fish, vaccinations, and occupational exposure such as
dental offices are other sources of significant mercury exposures. A nationwide
survey found that over 22 percent of those tested for mercury levels in the
hair had dangerous levels higher than the U.S. EPA mercury health reference
level (2). Toxic metal levels were measured in
6-24 hours urinary samples of 100 randomly chosen patients with chronic
conditions at the Institute of Integrative Medicine following a combined
EDTA/DMSA provocation challenge. Over 70% had levels of lead,
arsenic, mercury, or cadmium outside the Laboratory Reference Level (571).
Dr. Simon Yu(21), Dr. T. Levy(22), Dr. George
Meinig (24), and many of the other doctors and dentists
referenced here(21-33,52) point out that millions of patients have
medically unexplained symptoms/conditions and suffer and die from conditions
like Cancer, ALS, MS, ALZ, Parkinson’s, CFS, etc. -that could be cured or significantly
improved, but have underlying immune system disabling factors that usually
include parasitic infections, dental infections (root-canaled teeth, jaw- bone
cavitation infections, gum disease), toxic metal toxicity or other toxins,
nutritional factors, etc. These conditions can be tested for and treated by
knowledgeable doctors or dentists and usually improve (21-33), but most doctors
and dentists in the U.S. do not have proper training to know what to test for
or how to test for chronic conditions underlying immune disabling problems (21-33,52), etc.).
Dental amalgams
have been documented to be the largest source of mercury in most
people who have amalgam fillings, and also more on
average than those without amalgams. The studies also document that much of the
exposure is organic mercury since oral and intestinal bacteria convert
inorganic mercury to organic mercury. Galvanism in the mouth of those with
dental amalgam or gold crowns or mixed metals in the mouth through the battery effect causes electrical
currents and metals corrosion in the mouth that greatly increase mercury and
metals exposure and toxicity effects. Also EMF and wi-fi and
microwaves have been documented to increase mercury vapor release and exposure
in those with amalgam fillings, increasing damages from mercury and metals
toxicity.
A large U.S.
Centers for Disease Control epidemiological study,
NHANES III, found that those with more amalgam fillings (more
mercury exposure) have significantly higher levels of chronic health conditions
(543). The conditions in which the number of dental amalgam surfaces
were most highly correlated with disease incidence were MS, epilepsy,
migraines, mental disorders, diseases of the nervous system, disorders of the
thyroid gland, cancer, and infectious diseases (543,500). Large
numbers of patients with many such chronic conditions recovered or
significantly improved after amalgam replacement. For many chronic conditions,
clinical studies found the majority recovered or improved
after proper amalgam replacement with proper immune support.
Mercury and other
toxic metals such as copper and lead cause breaks in DNA
(4,8,38,41,42,197,272,296,500), and also have synergistic effects with
x-rays (296) and EMF. Several toxic
metals, including arsenic, cadmium, chromium, and nickel, have been documented
to be carcinogenic (5,496,497,498). Some of the mechanisms by which toxic
metals such as mercury causes cancer have
been documented by medical clinical studies
(4,5,8,17,18,19,100-102,500). A study on mercury tested at concentrations comparable with its occurrence
as environmental pollutant showed that Hg (II) elicits a prooxidative state in
keratinocytes linked to inhibition of gap junction-mediated intercellular
communication and proinflammatory cytokine production (8). These combined
effects appear to on one hand isolate cells from tissue-specific homeostasis
promoting their proliferation and on the other hand tamper the immune system
defense/surveillance checkmating the whole organism. Thus, mercury appears be
an example of an epigenetic tumor promoter or, further expanding this concept,
a "metagenetic" effector. Studies found mercury
occupational exposure had a significant association with lung and liver cancer
(20).
Low
non-cytotoxic levels of mercury induce dose dependent binding of mercury
to DNA and significantly increased cell mutations (142,4,18,500) and
birth defects (197,38,105). Compared to control, a total of 658 aberrant RNA alternative
splicing (AS) events were observed after MeHg exposure
(18). Proteomics and RNA-seq results also demonstrated that mercurychloride (HgCl2) influenced the
expression levels of several RNA splicing related proteins and 676 AS events
compared to control. These results suggested that RNA splicing could be a new
molecular mechanism involved in MeHg and
HgCl2 neurotoxicity (18). Numerous studies showed that lead and
mercury induce cancer in humans and also in animals, in vitro experiments with
cultured cells indicate that they cause DNA damage via different
molecular mechanisms including release of reactive oxygen species and
interactions with DNA repair processes (19). Also, in most human
studies, positive results were obtained in micronucleus MN tests with
lymphocytes (all 15 occupational studies with lead yielded positive results,
with mercury 6 out of 7 investigations were positive). For cadmium,
there is clear evidence that it causes cancer in humans; however,
induction of chromosomal damage was only seen in high dose experiments with
mammalian cells while results of human studies yielded conflicting results
(only in 2 of 5MN trials with humans), positive findings were reported).
Possibly, non-genotoxic mechanisms such as inhibition of apoptosis and
interaction with signaling pathways account for the carcinogenic properties of
cadmium species. The findings of MN studies with lead and mercury are
in excellent agreement with results which were obtained with other endpoints
(e.g. chromosomal aberrations and comet formations) In addition
to effects on DNA, mercury also promotes cancer in other ways. Mercury by
its effect of weakening the
immune system contributes to increased chronic diseases and cancer
(17,91,180,228a,237,239,222,234,355,369, 405,500,530,543,570, 35,38,40,
etc.).
Nobel Prize winner
Dr. Otto Warburg determined that cancer has only one prime cause
(581). It is the replacement of normal oxygen respiration of the body's cells
by an anaerobic [i.e., oxygen-deficient] cell respiration. Porphyrins are precursors
to heme, the oxygen carrying component of
blood. Mercury inhibits the conversion of specific porphyrins
to heme (84,35,201,539,500). Mercury has been
documented to bind to oxygen carrying sites in the blood, reducing a person’s
available oxygen supply. (232,233,570,571,500). Mercury binds with
hemoglobin, which is located inside the red blood cell and carries oxygen for
transport to tissues. Mercury bound to hemoglobin results in less oxygen
carrying capacity of the red blood cell and therefore less oxygen will reach
the tissues. The body senses the need for more oxygen and may attempt to
compensate for this by increasing the production of hemoglobin. A
normal or increased hemoglobin level combined with symptoms of lack of oxygen
(fatigue, weakness, appearing pale, rapid heart rate, shortness of breath,
etc.) could indicate mercury toxicity. But this can confuse some doctors since
the patient seems like they are anemic but in fact the blood counts seem fine
(233). A new well documented book has more information on causes of
cancer and effective natural treatments for cancer (560), including the
toxic teeth connection.
At the energetic-molecular level, the boundary between health and the state
of absence of health is marked by oxidosis,
acidosis, and dysoxygenosis (dysox). (571,581) There is but
one fundamental difference between a healthy cell and an unwell cell: a healthy
cell has a well preserved oxygen
homeostasis. A healthy cell utilizes oxygen well, without incremental oxidative
stress (oxidosis) and without accumulating organic
acids (acidosis). In contrast, an unwell cell cannot utilize oxygen
well and gets clogged up with Krebs cycle metabolites and other organic acids.
At the bioenergetic cellular level, all inflammatory, autoimmune, and
neurodegenerative disorders are caused by the oxygen disorder (dysfunctional
oxygen utilization) caused by cellular toxicity in the cells.
Mercury from dental amalgams appears to be one of the most, if not the
most, potent disrupters of oxygen metabolism in the oral cavity (571,233).
Other such disrupters are thioethers related to root canal
teeth or cavitations and other microbial toxins. Those factors also alter the
local conditions that either inhibit or foster microbial growth, so
facilitating biofilm formation. Such dynamics seem to play crucial roles in the
pathogenesis of systemic disorders rooted in the oral cavity. The
crucial importance of oral toxicity in triggering, amplifying, and perpetuating
systemic inflammatory and infectious disorders has largely been ignored by most
doctors and dentists. The presence of the cellular dysox state can be readily documented by the
measurement of 24-hour urinary excretion of organic acids.
Mercury has been
found to bind oxygen binding sites in hemoglobin, thus reducing access to
oxygen carried by the blood (232,233,35,582). Oxyhemoglobin saturation
levels in venous blood should be at least 60% for normal levels. The majority
of a group of 27 patients with amalgam dental fillings suffering from chronic
fatigue whose oxyhemoglobin was tested had lower than
normal oxyhemoglobin saturation levels
(232,35). After amalgam replacement the majority of those
with oxyhemoglobin levels equal to or less than 45% had significant
increases in oxyhemoglobin saturation levels, on average about
15%. Heme is used for 2 main functions, in red blood cells and in
production of energy by enzymatic processes in the ATP cytochromeoxidaze system. Mercury
and other toxics have been documented to block these enzymatic processes,
resulting in dumping porphyrin wastes into the urine rather than
completing the proper heme functions. The level of
these porphyrins in the urine can be measured by a standard urine
test, the fractionated porphyrin test, and indicate the level of
toxic disruption of the basic enzymatic ATP production process. The
majority of the patients in the study had high levels
of porphyrins in the urine, which decreased significantly after
amalgam replacement. This has also been confirmed by
other studies (260,233).
Mercury from amalgam binds to the -SH
(sulfhydryl) groups, resulting in inactivation of sulfur and blocking of enzyme
functions such as cysteine dioxygenase (CDO), gamma‑ glutamyltraspeptidase (GGC) and sulfite oxidase,
producing sulfur metabolites with extreme toxicity that the body is unable to
properly detoxify (33,111,114,405), along with a deficiency in sulfates
required for many body functions. Sulfur is essential in enzymes,
hormones, nerve tissue, and red blood cells. These exist in almost
every enzymatic process in the body Mercury also blocks the metabolic action of
manganese and the entry of calcium ions into cytoplasm (333). Mercury from
amalgam thus has the potential to disturb all metabolic processes
(34,35,60,111,114,180,181,194,333,405,500). Mercury is transported throughout
the body in blood and can affect cells in the body and organs in different ways
causing numerous types of chronic health conditions including blood conditions
and cancer.
Mercury has a high
affinity for and readily binds to selenium and to the thiol or sulfhydryl
(sulfur/hydrogen combination) sites in living tissues. The higher the
attraction between chemicals or elements, the stronger they bond to each other,
and the harder it is to separate them. The thiol combination is
extremely common in the human body. It occurs as part of certain amino acids,
which are building blocks of proteins. Since these amino acids are used to
build cells, hormones, and enzymes, the occurrence of
the thiol combination in the body is not only common but extremely
important, as normal function is altered. There are several thiol sites
in the hemoglobin molecule in the red blood cells used to transport oxygen
throughout the body. Mercury accumulates in red blood cells in humans and other
animals. When mercury attaches to the thiol sites, the hemoglobin
can't carry as much oxygen as it could. This results in decreased availability
of oxygen (hypoxia) that is needed by all body cells and explains one
way that mercury toxicity can cause chronic fatigue symptoms and other effects
of low oxygen levels in the cells.
Toxic
metal exposure’s adverse influence on thyrocytes can play a major role in
thyroid cancer etiology (144,500). Among those with chronic immune system
problems with related immune antibodies, the types showing the highest level of
antibody reductions after amalgam removal include thyroglobulin and microsomal
thyroid antigens (91,369). Similar results regarding mercury have
been found for treatment of other types of cancer. Studies have
found conventional chemotherapy (alone) to be only a little more effective than
no treatment and clinical cases have demonstrated that detoxification and
nutritional support can be effective in treating multiple myeloma
(550,7,6) and other cancers (486,530,572,35,228a). For more on treating cancer
see “Causes of Cancer and Natural
Treatments”.
Exposure
to mercury vapor causes decreased zinc, selenium,
and methionine availability, depresses rates of methylation, and
increased free radicals- all factors in increased susceptibility to cancer and
other chronic conditions (14,17,34,38,43,143,144,180,237,239,251,256,283,530).
Amalgam fillings have also been found to be positively associated with oral
cancer (206,251,403). Mercury from amalgam fillings has also been found to
cause increase in white blood cells and in some cases to result in leukemia
(35,180). There is evidence that some forms of leukemia are abnormal
response to antigenic stimulation by mercury or other such toxics, and total
dental revision including removal of amalgam has led to remission very rapidly
in some cases (35,38,180,239,500). Among a group of patients
testing positive as allergic to mercury, low level mercury exposure was found to
cause adverse immune system response, including effects on vitro production of
tumor necrosis factor TNF alfa and reductions in interleukin-1.
(126,131,152)
Mercury has been
found to cause decreased sperm volume and motility, increased sperm
abnormalities and spontaneous abortions, increased uterine fibroids/
endometritis, and decreased fertility in animals (4,104,105,162) and in humans
(9,10,23,31,37,105,146,159, 395,433,27,35,38). In studies of
women having miscarriages or birth defects, husbands were found to typically
have low sperm counts and significantly more visually abnormal sperm
(393). It's now estimated that up to 85 per cent of the sperm produced by a
healthy male is DNA-damaged (433). Abnormal sperm is also
being blamed for a global increase in testicular cancer, birth
defects, and other reproductive conditions.
There are extensive
documented cases (many thousands) where removal of amalgam fillings led to cure
or significant improvement of serious health problems such
as oral keratosis (pre cancer) (87,251), cancer (breast, leukemia,
etc.) (35,38,94,180,228a,469,486,487,500, 530).
Some
studies have found increased risk of lung, kidney, brain,
and CNS system cancers among dental workers
(34,99,143,283). Other studies reviewed found increased rates of
brain cancer related to mercury exposure (193,383,328). Dr. Max Daunderer's serial biopsies on malignant tumors
in-patients that had amalgam fillings found toxic metals contained in
amalgam in the tumor. The concentration is highest in the center of the tumor
(malignant melanoma, brain cancer, bladder, stomach, colon and tongue
cancer). (570) An occupational study found that Occupations with
likely exposure to mercury or arsenic such as dental nurses displayed increased
risk of melanoma (14). For tests & detox, see(6).
Some
studies have also found persons with chronic exposure to
electromagnetic fields (EMF)
to have higher release of mercury from dental amalgam, higher levels of mercury
exposure and excretion (28,251c) and higher likelihood of getting chronic
conditions like ALS (526) and Alzheimers (251c)
and cancer (546).
Mercury causes
significant destruction of stomach and intestine epithelial cells, resulting
in damage to stomach lining which along with mercury’s
ability to bind to SH hydroxyl radical in cell membranes alters permeability
(338,405,35,21c) and adversely alters bacterial populations in the intestines-
causing leaky gut syndrome with toxic, incompletely digested complexes in the
blood(222,228b,35) and accumulation of heliobacter pylori,
a suspected major factor in stomach ulcers and stomach cancer (256)
and candida albicans (404), as well as poor nutrient
absorption.
From extensive
clinical experience the spread of cancer has been commonly found to be related
to fungal/Candida incidence, and treating
Candida through blood alkalinity balance and reduction of toxic metals body
level has been found to reduce the spread of cancer(233a). Such
treatments also increase oxygen supply to the cells. (580). An
anaerobic environment favors the development of yeast infections and
cancer, since yeast is a fermenting spore and cancer is a fermenting cell
rather than a normal respiratory (oxygen using) cell.
Mercury has a
symbiotic relation to Candida in the body and promotes the proliferation of
Candida. Mercury impairs the body�s ability to kill
Candida albicans by impairment of the lytic activity
of neutrophils and myeloperoxidase in workers whose mercury
excretion levels are within current safety limits
(233,285,404). Immune Th1 cells inhibit Candida by cytokine related
activation of macrophages and neutrophils. Development of Th2
type immune responses deactivate such defenses(404b,181). Mercury inhibits
macrophage and neutrophil defense against Candida by its effects on
Th1 and Th2 cytokine effects (181,285,404b). Candida
also methylates inorganic mercury to the highly toxic methyl mercury
form which like mercury vapor readily crosses the blood-brain barrier, causes
neurological damage, and weakens the immune
system (225,405). Candidiasis is often observed
in immunocompromised individuals such as those with toxic metal
exposures, especially those who are found by test to be immune reactive to
mercury or other toxic metals (60,235,405). Amalgam replacement cures or
significantly improves Candida (404,222,35, etc.),
Nickel and
beryllium are 2 other metals commonly used in dentistry that are very
carcinogenic, toxic, and cause DNA malformations
(35,456,560,13). Nickel ceramic crowns, root canals and cavitations have also been found to be a factor in
some breast cancer and other cancers and some have recovered after TDR,
which includes amalgam replacement, replacement of metal crowns over amalgam,
nickel crowns, extraction of root canaled teeth, and treatment
of cavitations where necessary
(35,200,228a,486,530,560). Nickel depletes intracellular ascorbate, which
leads to the inhibition of cellular hydroxylases, manifested by the loss
of hypoxia-inducible factor (HIF)-1alpha and -2alpha hydroxylation and
hypoxia-like stress (13). Proline hydroxylation is crucial for collagen
and extracellular matrix assembly as well as for assembly of other protein
molecules that have collagen-like domains, including surfactants and complement.
Thus, the depletion of ascorbate by chronic exposure to nickel could
be deleterious for lung cells and may lead to lung cancer.
Root canals and cavitations also facilitate cancer by effect
on immune system. (570,560) As more information is accumulated it is apparent that these areas
(bone cavitations) of chronic infection in the
craniofacial area are very real and the probable cause of multiple painful
conditions in the head, neck and tooth area. (571) This is due
in part to the progressive loss of vascularity in the jaw bones and associated
structures. This allows the pathogenic anaerobic microbial population to exist
and create a chronic infected, inflamed area. This area is effectively isolated
from the circulatory system which is responsible for delivering any
anti-microbial medications to the infected area. These types of bone cavities
have also been shown to have accumulations of toxic heavy metals, as well as
the pathogenic microbes. There have been considerable numbers of
cases documented of recovery from cancer after dealing with oral infections
such as root canals and cavitations. (571,560,
etc.) (T: test root canal teeth toxicity & extract and treat if needed)
Prostate
cancer is the most commonly diagnosed cancer in men in the US. Over
300,000 new prostate cancer cases are diagnosed annually, constituting about
30% of all new male cancer cases, and more than 40,000 men die from the disease
each year (490). Both breast cancer and prostate cancer are
hormonally responsive, containing estrogen, androgen, and progesterone
receptors. Genetic susceptibility and environmental factors that promote the
sequence that results in clinical prostate cancer have been found to be factors
in prostate cancer, with environmental factors being the larger with exposures
in early life facilitating later effects. Low-level developmental exposures to
substances that modulate endocrine activity can have life-
long impacts if the exposure occurs during window(s) of unique
vulnerability.
Cadmium and
arsenic are known human carcinogens and are linked to prostate & breast
cancer in epidemiologic and laboratory animal studies. Arsenic has also been shown to be a
factor in Lung cancer, Bladder cancer, Skin cancer, digestive tract, liver, kidney, urothelial,
and lymphatic and hematopoietic systems (496). Cadmium and arsenic have also been found to be
associated with lung cancer (491e,494c, etc.) Food, cigarette
smoke, and well water are 3 sources of cadmium exposure. Cadmium has been found to be a cause of breast, lung, prostate,
nasopharynx, pancreas, kidney, renal, & bladder cancer (497). T: test &
detox (6, Pectasol, etc. )
Selenium (Se) in a large-scale human
supplementation trial has been shown to significantly reduce the incidence of
prostate cancer in elderly men. Because Se is known to interact with
cadmium (Cd), it has been suggested that its cancer protective action could be
attributable in part to its interaction with cadmium (11). The excessive accumulation of Cd in
the prostates of smokers along with sub-optimal Se intakes could explain why
smokers develop more aggressive and lethal forms of prostate cancer than
nonsmokers. Toxic metals
such as mercury, lead, cadmium, and nickel have been found to promote prostate
cancer, and reducing toxic metal exposures and detoxification with nutritional
support have been found to cure or result in significant improvement in the
condition (490,491,486,530,531,572,11,35).
A substantial number of environmental pollutants, such as
polychlorinated biphenyls, dioxins, polycyclic aromatic hydrocarbons,
phthalates, bisphenol A, pesticides, herbicides, alkylphenols and heavy metals
(arsenic, cadmium, lead, mercury), have been shown to disrupt endocrine
function. (100) Endocrine disrupting chemicals can cause cancer, diabetes,
obesity, metabolic diseases and developmental problems (100,101). These compounds can
cause reproductive problems by decreasing sperm count and quality, increasing the
number of testicular germ cells and causing male breast cancer, cryptorchidism,
hypospadias, miscarriages, endometriosis, impaired fertility, irregularities of
the menstrual cycle, and infertility. (100) Endocrine disrupting chemicals have endocrine disrupting
abilities in females during adult life, causing fertility abnormalities in both
humans and animals (101).
Dietary factors such as consumption level
of red meat, refined carbohydrates, and environmental exposures to estrogenic
chemicals have been found to increase the incidence of both prostate and
breast cancer (490,560,100,101). Many occupational studies show an
increased incidence of prostate
cancer incidence and/or mortality among farmers and pesticide
applicators(102). One in vitro study of human prostate cancer cells
showed that several organochlorine pesticides, a pyrethroid, and a fungicide
each caused proliferation of androgen-dependent cancer cells (490). Another
environmental estrogen, bisphenol A (BPA-a component of epoxy resins,
polycarbonate plastic, and dental sealants to which the general population
is exposed at low levels), has been found to affect the
prostate and be related to development of prostate cancer (490).
The
toxic metals mercury, lead, cadmium, copper, cobalt, nickel, lead, aluminum,
and tin have been found to have reproductive and endocrine system disrupting
effects (10,12,100), as well as synergistic effects. The
ability of metals to activate estrogen receptor-alpha (ERalpha)
was measured in the human breast cancer cell line, MCF-7. Similar
to estradiol, treatment of cells with the divalent metals copper, cobalt,
nickel, lead, mercury, tin, and chromium or with the metal
anion vanadate stimulated cell proliferation; by day 6, there was a
2- to 5-fold increase in cell number. The metals also decreased the
concentration of ERalpha protein and mRNA
by 40-60% and induced expression of the estrogen-regulated genes progesterone
receptor and pS2 by1.6- to 4-fold. Furthermore, there was a 2- to 4-fold
increase in chloramphenicolacetyltransferase activity
after treatment with the metals in COS-1 cells transiently cotransfected with the wild-type receptor and an
estrogen-responsive chloramphenicol acetyltransferase reporter gene. The
ability of the metals to alter gene expression was blocked by
an antiestrogen, suggesting that the activity of these compounds is
mediated by ER alpha (10,12). Aluminum in
the form of aluminum chloride or aluminium chlorhydrate, which are used in antiperspirants, can
interfere with the function of oestrogen receptors
of MCF7 human breast cancer cells both in terms of ligand binding and
in terms of oestrogen-regulated reporter
gene expression (12).
Cancer Treatments
As
previously seen, there are several estrogenic or carcinogenic metals (100, etc.), and clinical experience
has found metals detoxification to be beneficial in cancer case treatment(6).
There are also diet measures and supplements that have been found to be
beneficial in preventing or treating cancer. A comprehensive and well
documented summary of natural cancer treatments clinically documented to be
effective in treating cancer is Outsmarting Your Cancer (560).
Many effective options are covered, with considerable detail and
documentation. Another source of such information in Cancer and Natural Treatments for
Cancer
Vit K2, Vit D,
zinc, and green tea have all been found to be effective in preventing or
treatment of prostate cancer and other types of cancer(501-503,493a).
Black tea theaflavins have been found to be
effective at prevention of cigarette smoke-induced lung damage
and cancer (504), and have demonstrated
effectiveness in switching off the genes involved in many types of cancer
(505). Studies have shown theaflavin supplementation significantly reduces
levels of inflammatory cytokines such as TNF-alpha, Il-6, Il-8, and C-reactive
protein; and lowered rates of production of inflammation-generating trasnscription factor NF-kB, cytokine generating
COX-2, and the adhesion molecule ICAM-1(506). Vitamin K2 has been shown to
induce apoptosis in leukemia cells in vitro and inhibitory effects against
myeloma and lymphoma, as well as being effective at reducing liver cancer in
patients with hepatitis B or C(known risk factors for liver cancer), and
also to be effective at reducing rate of re-occurrence of liver cancer in liver
cancer patients in remission(506). Apatone (Vit C
& Vit K3) was demonstrated to significantly delay cancer
progression in a group of end stage prostate cancer patients.
Patients with advanced cancer have
been found to be vitamin K deficient and it is recommended to monitor levels
and supplement where needed (506). Several studies found
evidence of benefit of intravenous Vit C in treatment of cancer
(15). A connection between cancer and fungus/candida has been
demonstrated and many types of cancers have been successfully treated using
sodium bicarbonate in the treatment (551,552). Adding Ľ teaspoon of sodium
bicarbonate to morning coffee has been suggested by doctors as preventative.
Magnesium and Iodine have also been found beneficial in treating cancer
(552) and flax oil with cottage cheese which addresses common digestive
problems that can be related to cancer (553). Supplementation with chlorella
has been found to result in beneficial effects when used in cancer patients or
for other chronic conditions such as ulcerative colitis, hypertention, or Fibromyalgia (572). Doctors such as
D. Klinghardt have suggested that the
mechanism by which chlorella improves treatment of such conditions is metals
detoxification, which is the main mechanism of action of chlorella.
People who drink
two or more high fructose syrup sweetened soft drinks a week have a much higher
(87%) risk of pancreatic cancer. The high levels of sugar in soft drinks may be
increasing the level of insulin in the body, which the authors think
contributes to pancreatic cancer cell growth (495).
References
(1) Documentation
of the average level of mercury exposure from dental amalgam fillings, DAMS
Intl, B. Windham, Ed.
(2) An Investigation of Factors Related to Levels of
Mercury in Human
Hair, Environmental Quality
Institute, October 01, 2005, Greenpeace
Report
(3) Mercury in Pancreatic Cells of People
with and without Pancreatic Cancer, Int J Environ Res Public Health, 2020 Dec 2;17(23):8990.
https://pubmed.ncbi.nlm.nih.gov/33276658/
(b) Toxic
metals show evidence of carcinogenic and estrogenic properties. Epidemiology, 2019 Jan;30(1):20-28. 2019 Jan;30(1):20-28. https://pubmed.ncbi.nlm.nih.gov/30198937/
&
(c) Possible Mechanisms of Mercury Toxicity and Cancer Promotion: Involvement
of Gap Junction Intercellular Communications and Inflammatory Cytokines, Oxid
Med Cell Longev, 2017;2017:7028583.
https://pubmed.ncbi.nlm.nih.gov/29430283/
(4) Lee IP, Effects of Mercury on Spermatogenisis, J
Pharmacol Exp Thera 1975, 194(1);171- 181; &
Ben-Ozer
EY Rosenspire AJ,
et al, Mercuric chloride damages
cellular DNA by a
non-apoptotic mechanism. Mutat Res.
2000 Oct 10;470(1):19-27;
& Ogura H, Takeuchi T,
Morimoto K, A comparison
of chromosome aberrations and
micronucleus techniques for
the assessment of the
genotoxicity of
mercury compounds in human blood
lymphocytes. Mutat Res 1996 Jun;340(2‑3):175‑82
(5) Metal ions and carcinogenesis, Durham TR, Snow ET.,
EXS. 2006;(96):97-130; & (b) Estrogen-like activity of
metals in MCF-7
breast cancer cells.
Martin MB, Reiter R, Pham T, Avellanet YR, Camara J,
Stoica A,
Endocrinology. 2003 Jun;144(6):2425-36, & (c) Aluminium,
antiperspirants and breast
cancer. Darbre P D., Division of Cell and
Molecular Biology,
School of Animal and Microbial Sciences,
The University of Reading,
P.O. Box 228, Whiteknights, Reading, RG6
6AJ, UK. J Inorg Biochem. 2005 Se
p;99(9):1912-9, & (d) Ascorbate
depletion: a critical step
in nickel carcinogenesis? Salnikow K,Kasprzak KS.,
Laboratory of Comparative
Carcinogenesis, Building 538, Room 205 E.,
National Cancer Institute
at Frederick/NIH, Frederick, MD 21702,
USA., Environ Health Perspect. 2005 May;113(5):577-84. &
(e) Cutaneous melanoma in Swedish women: Occupational
risks by
anatomic site. Perez-Gomez
B, B, Aragones, Lopez-Abente G, Pollan
M,
Cancer and Environmental
Epidemiology Section, National Center for
Epidemiology,
Carlos III Institute of Health, Madrid, Spain. Am
J Ind Med.
2005 Oct;48(4):270-81,
& (f) Increased levels of transition metals in breast
cancer
tissue. Ionescu JG, Novotny J, Stejskal VD, Latsch A, Blaurock-
Busch E, Research Department of Spezialklinik
Neukirchen, Neukirchen,
Germany. Neuro Endocrinol Lett. 2006
Aug 5;27(Suppl1). & (g) Biliary
heavy metal
concentrations in carcinoma of the gall bladder: case-control
study, Shukla VK
et al, Departments of Surgery and Community Medicine,
Institute of Medical Sciences,
Banaras Hindu University, Varanasi – 221
005, India, British
Medical Journal 1998;317:1288-1289,
http://www.melisa.org/abstracts.php#1
& (b) Take
Charge of Your Health (Testing & Chelation of Heavy Metals) - Dr. Chris
Shade - CEO of Quicksilver Scientific https://s115.podbean.com/pb/1860a0ddeed2ad45db31477355f265e8/60103875/data1/fs48/6936790/uploads/Take_Charge_1218208ati1.mp3?pbss=f02615a5-91d0-5c11-8e0e-81cca9f7c721
(7) Environmental
Mercury and Its Toxic Effects, J Prev Med Public Health. 2014 Mar; 47(2): 74–83.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3988285/
(8) Possible Mechanisms
of Mercury Toxicity and Cancer Promotion: Involvement of
Gap Junction Intercellular Communications and Inflammatory Cytokines. Zefferino R, PiccoliC,
et al; Oxid Med Cell Longev. 2017; 2017: 7028583.
(9) Heavy Metals and Fertility, J of Toxicology and Environmental
Health, Part A, 54(8):593-611, 1998; Gerhard I, Monga B, Waldbrenner A, Runnebaum B
& (c) Impact of heavy metals on hormonal and immunological factors in
women with repeated miscarriages, Hum Reprod Update
1998 May;4(3):301‑309; Gerhard I, Waibel S, Daniel V, Runnebaum B,
(10) Estrogen-like activity of
metals in MCF-7 breast cancer cells. Martin MB, Reiter R, et al,
Endocrinology. 2003 Jun;144(6):2425-36; & Dr.T. Colborn, D.Dumanoski, JP Myers (Ed.), Our Stolen
Future Dutton Books, NY, 1996;
(11) Selenium/cadmium ratios in human prostates: indicators of prostate
cancer risk of smokers and nonsmokers, and relevance to the cancer protective
effects ofselenium. Drasch G, Schopfer J, Schrauzer GN., Biol Trace
Elem Res. 2005 Feb;103(2):103-7.
(12) Aluminium, antiperspirants and breast cancer. Darbre PD.,
J Inorg Biochem.
2005 Se p;99(9):1912-9.
(13) Ascorbate depletion: a critical step in nickel carcinogenicis? Salnikow K, Kasprzak KS., Environ
Health Perspect. 2005 May;113(5):577-84.
(14) Cutaneous melanoma
in Swedish women: Occupational risks by anatomic site. Perez-Gomez B, Aragones N, et al, Am J Ind Med. 2005
Oct;48(4):270-81.
(15) Intravenously administered vitamin C as cancer therapy: three
cases. Padayatty SJ,
Riordan HD, Hewitt SM, Katz A, Hoffer LJ, Levine M., CMAJ. 2006
Mar 28;174(7):937-42; & Vitamin C Pharmacokinetics: Implications for Oral
and Intravenous Use, Padayatty, et al. Ann
Intern Med. 2004 Apr 6;140(7):533-; & Orthomolecular oncology review:
ascorbic acid and cancer 25 years later, Gonzalez MJ, Miranda-Massari JR et al, Integr Cancer Ther. 2005 Mar;4 (1):32-44.
(16) Increased levels of transition metals in breast cancer
tissue. Ionescu JG, Novotny
J, Stejskal VD, Latsch A, Blaurock-Busch E, Eisenmann-Klein M, Neuro Endocrinol Lett. 2006 Aug
5;27(Suppl1)
(17) Environmental Mercury and Its Toxic Effects, J Prev Med Public Health. 2014 Mar; 47(2): 74–83. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3988285/
(18) Methylmercury exposure alters RNA splicing in human
neuroblastoma SK-N-SH cells: Implications from proteomic and
post-transcriptional responses. Li Y, He B, Liu QS et al; Environ Pollut. 2018 Jul;238:213-221.
(19) Results of micronucleus assays with individuals who are
occupationally and environmentally exposed to mercury, lead and
cadmium. Nersesyan A, Kundi M et al; MutatRes. 2016 Oct - Dec;770(Pt
A):119-139.
(20) Mortality and cancer incidence in chloralkali workers exposed to inorganic mercury; , BMJ, Occup Environ Med, http://dx.doi.org/10.1136/oem.47.2.99; & (b) Cancer occurrence among European mercury miners, Cancer Causes & Control, 9, 591–599(1998) https://link.springer.com/article/10.1023/A:1008849208686
(21) Accidental
Blowup in Medicine, Dr. Simon Yu, 2019; & (b) Impact of
Endodontically Treated Teeth on Systemic Diseases, Dentistry 2018, 8:3 Johann Lechner and Volker von Baehr; & (c) THE ROOT CANAL AND BREAST-CANCER CONNECTION, AliReza PaNahPouR,D.D.s.
, https://iaomt.org/wp-content/uploads/Unit-9-REQUIRED-Accred..pdf
(22) THE ROOTS OF DISEASE, DR. T LEVY, & HIDDEN
EPIDEMIC, SILENT ORAL INFECTIONS CAUSE MOST HEART ATTACKS AND BREAST CANCER,
DR. T LEVY, 2017.
(23) Toxic Root Canals, Dr. T. Levy, The Toxic Tooth;& Dr.
J. Mercola, Root Canals Linked to Heart Disease and
Inflammatory Conditions,;
& TOXIC BACTERIA IN TEETH CONTRIBUTES TO ILLNESS
THROUGHOUT THE BODY,
(24) ROOT CANAL COVERUP, DR. G.MEINIG DDS; & HTTPS://WWW.FOODMATTERS.COM/ARTICLE/ROOT-CANAL-COVER-UP-EXPOSED: & WESTON PRICE FINDINGS,
(25) Cancer/Root
Canals, https://www.cancertutor.com/advdental/
(26) (a) Root Canals & Cancer (issels, diamond,huggins)
http://www.whale.to/d/root2.html; & (b) Many cancer doctors in Europe and elsewhere
urge removal of root canal teeth before cancer fighting treatments are
administered. http://www.annieappleseedproject.org/dentalissues.html;
&
(c) The
Relationship Between Root Canals and Cancer, Independent Cancer Research
Foundation, &(d) Dr.
Robert Kulacz's The Roots of Disease:
Connecting Dentistry and Medicine, Root Canals and Cancer, (see29-31)
& (e) Cancer Care Expert
Details-Root Canal Case Studies :
https://www.westonaprice.org/health-topics/dentistry/root-canal-dangers/
& (f) Central
(intraosseous) adenoid cystic carcinoma of the mandible: report of a case
with periapical involvement. J Endod. 2000
Dec;26(12):760-3, Favia G, Maiorano E, Orsini G, Piattelli A.
(27) . Dr. Frank Shallenberger, Second Opinion: Healing Series,
V2,2015, & Second Opinion,
Journal of Natural Health, 2016-2018, https://www.secondopinionnewsletter.com/Home.htm& (b)Potpourri of Healing
Secrets, 2015; & The Nevada Center
for Alternative and Anti-Aging Medicine; &(c) The Ozone Miracle: How you can
harness the power of oxygen to keep you and your family healthy
(28) Dr. Joseph Mercola, https://www.mercola.com & Vitamin D from sunshine exposure, , https://search.mercola.com/results.aspx?q=prostate%20cancer#stq=prostate%20cancer ,
(29) 40. Dr. Bruce West, Doctors A-Z Phytoceutical
Guide; & (b) Health
Alert, 2017-2019, & Health
Alert Store, ; &(c)
)National Health and Nutrition Examination Survey, 2015 (26,000 adults); & (f) Dr. Ralph Moss, The Ultimate
Guide to Cancer,; & (g) [HTML] nih.gov
(30) . (a)
The Complete Guide to Reversing Alzheimers, Dr, Glen Rothfeld, & (b) 81 Natural Cures for Cancer, Alzheimers, Diabetes, etc. Dr. Rothfeld,
& & (f) Dr. Rothfeld’s
Secrets to a Disease- Free Life; & (g) The Best of Nutrition & Healing,
Vol. XVII
110. Biomed Rep. 2016 Sep; 5(3): 283–288. Potential role of
bromelain in clinical and therapeutic applications, Vidhya Rathnavelu et al
(32) Recovery from Chronic Conditions
after dental amalgam replacement, dental revision, and detoxification, DAMS
Intl. B. Windham, Ed.
(33) B. Windham, DAMS Intl, Mercury or toxic metals exposure and
health effects & Diagnosing and Treating Toxic Metal related Chronic
Conditions, (over 5000
peer-reviewed studies cited); &(b) High Dose Vitamin C -Prevention and Treatment of Chronic
Health Problems including Coronavirus,
& & (c) Vit C treatment of
Cancer - Mercury/Toxic Metals
& Cancer,
(34) Patrick Stortebecker,Associate Professor
of Neurology, Karolinska Institute, Stockholm. Mercury
Poisoning from Dental amalgam-A Hazard to the Human Brains, ISBN:
0-941011001-1
(35) (a)Huggins
HA, Levy,TE, Uniformed
Consent: the hidden dangers in dental care, 1999, Hampton Roads Publishing
Company Inc; & (c) Toxic Elements Research Foundation, Colorado
Springs Colorado, Survey of 1320 patients being treated for heavy metal
toxicity, 2001. 800-331-2303 www. peakenergy.com
(38) S.Ziff and M.Ziff, Infertility and Birth Defects:
Is
Mercury from Dental
Fillings a Hidden Cause?, Bio-Probe,
Inc. ISBN:
0-941011-03-8.1987
(39) (a) Markovich et al, "Heavy metals
(Hg,Cd) inhibit the activity
of the liver and kidney sulfate transporter Sat‑1", Toxicol Appl Pharmacol,
1999,154(2):181‑7; & (b)2S.A.McFadden, Xenobiotic metabolism and
adverse environmental response: sulfur dependent detox pathways, Toxicology,
1996, 111(1-3):43-65; & (c) SO2: a potent glutathione depleting agent, Comp Biochem Physiol Pharmocol Toxicol Endocrinol,
114(2):89-98.
(41) Khera et al.,Teratogenic and
genetic effects
of Mercury toxicity.
The biochemistry of Mercury in the
environment Nriagu, J.O.Ed,
Amsterdam, Elsevier,
503‑18,1979; &
Teratology, 8: 293-304;
& Prati M, Gornati R, Boracchi P, Biganzoli E, A
comparative
study of the toxicity of
mercury dichloride and
methylmercury, assayed by the Frog Embryo
Teratogenesis Assay—Xenopus
(FETAX). Altern Lab Anim.
2002
Jan-Feb;30(1):23-32.
(42) The mediation of mutagenicity and clastogenicity of
heavy metals by
physiochemical factors. Environ Res.,
1985:37;253‑286, & K.Hansen et
al A survey of metal
induced mutagenicity in vitro and in vivo, Babich et al.,
J Amer Coll Toxicol, 1984:3;381‑430; & Rodgers
JS, Hocker JR, et al, Mercuric
ion inhibition of eukaryotic
transcription factor
binding to DNA. Biochem Pharmacol.
2001 Jun 15;61(12):1543-50.
(43) M. J. McCabe, University of Rochester School of
Medicine & Dentistry,
2002, Mechanisms of
Immunomodulation by
Metals,
www2.envmed.rochester.edu/envmed/TOX/faculty/mccabe.html;
(52) Life Extension, Disease Prevention and Treatment, Fifth Edition,
2013; & Life
Extension Disease Prevention and Treatment Book, 6th Edition; & (b) Life Extension Magazine, www.lifeextension.com &
Life Extension Magazine, Jan 2009,July
2018, etc.
(60)Melisa Medica Foundation, http://www.melisa.org/candida.php ;
& VDM Stejskal et al, "MELISA: tool for the study of
metal allergy", Toxicology in Vitro, 8(5):991-1000, 1994;
(84) J.C. Veltman et
al, Alterations of heme, cytochrome P-450, and steroid
metabolism
by mercury in rat adrenal gland, Arch Biochem Biophys, 1986,
248(2):467-78; & Porphyrinurias Induced
by Mercury and Other Metals,
B.A.
Fowler, J.S. Woods, et al, Toxicological Sciences 61, 197-198
(2001), & A.G.Riedl et al, Neurodegenerative Disease Research
Center,
King�s College, UK, P450 and hemeoxygenase enzymes
in the basal
ganglia
and their roles in Parkinsons disease,
Adv Neurol, 1999; 80:271-
86.
(87) P.O.Ostman et al, Amalgam-associated
oral lichenoid reactions: Clinical
& histologic changes after removal of
amalgam, Oral Surgery, Oral
Medicine, and Endodontics, 1996, 81(4):459-465; & S.H.
Ibbotson et al, The relevance of amalgam replacement on
oral lichenoid reactions, British Journal of Dermatology,
134(3):420-3, 1996; (270
cases)
(91) B. Lindqvist et al,
"Effects of removing amalgam fillings from patients with diseases
affecting the immune system", Med Sci Res 24(5): 355-356, 1996.
(94) F.Berglund, Case reports
spanning 150 years on the adverse effects of dental amalgam,
Bio-Probe, Inc.,Orlando,Fl,1995;ISBN 0-9410011-14-3(245
cured);
(99) M. Nylander et
al, Mercury accumulation in tissues from dental staff and controls,
Swedish Dental Journal, 13:235-243, 1989
(100) Dyer C.A. (2007) Heavy Metals as Endocrine-Disrupting
Chemicals. In: Gore A.C. (eds) Endocrine-Disrupting Chemicals. Contemporary
Endocrinology. Humana Press. https://doi.org/10.1007/1-59745-107-X_5
; & (b) Toxic metals show evidence of
carcinogenic and estrogenic properties. Epidemiology, 2019 Jan;30(1):20-28. 2019 Jan;30(1):20-28. https://pubmed.ncbi.nlm.nih.gov/30198937/
&
(c) Possible Mechanisms of Mercury Toxicity and Cancer Promotion:
Involvement of Gap Junction Intercellular Communications and Inflammatory
Cytokines, Oxid Med Cell Longev, 2017;2017:7028583. https://pubmed.ncbi.nlm.nih.gov/29430283/
(101) Computational
study involving identification of endocrine disrupting potential of herbicides:
Its implication in TDS and cancer progression in CRPC patients. [Ahmad MI, Usman A, Ahmad M. 2017. Chemosphere. 173:395-403.];
& (b) Negative impact of
endocrine-disrupting compounds on human reproductive health, Reproduction,
Fertility and Development 23 (3)
403-416 https://doi.org/10.1071/RD09300;
& (c) Exposure to endocrine
disruptors during adulthood: consequences for female fertility, Journal of
Endocrinology, Vol 233, Issue 3, June 2017 https://joe.bioscientifica.com/view/journals/joe/233/3/R109
(102) Beyond Pesticides: Pesticide & Cancer Database (see study
documentation for this category)- https://www.beyondpesticides.org/resources/pesticide-induced-diseases-database/cancer
(105) T.Colborn (Ed.), Chemically
Induced Alterations in Functional Development, Princeton Scientific
Press,1992; & Developmental Effects of Endocrine-Disrupting
Chemicals", Environ Heath Perspectives, V 101, No.5, Oct 1993
(111) (a) Quig D, Doctors Data Lab,"Cysteine metabolism
and metal toxicity", Altern Med Rev, 1998;3:4,
p262‑270, & (b) J. de Ceaurriz et
al, Role of gamma- glutamyltraspeptidase (GGC) and
extracellular glutathione in dissipation of inorganic mercury",J Appl Toxicol,1994,
14(3): 201
(114) M.
Aschner et al, Metallothionein induction in
fetal rat brain by in utero exposure to elemental mercury vapor,
Brain Research, 1997, dec 5, 778(1):222-32 & Aschner M, Rising
L, Mullaney KJ. Differential sensitivity of neonatal
rat astrocyte cultures to mercuric chloride (MC)
and methylmercury (MeHg): studies on K+ and
amino acid transport and metallothionein (MT)
induction. Neurotoxicology. 1996 Spring;17(1):107-16.
& T.V. O Halloran, Transition metals in control of gene expression,
Science, 1993, 261(5122):715-25;
(131) Christensen
MM, Ellermann Eriksen S, Mogensen SC. Influence of mercury chloride
on resistance to generalized infection with herpes simplex virus type 2 in
mice. Toxicology 1996, 114(1): 57-66; & S.
Ellermann-Eriksen et al, "Effect of mercuric
chloride on macrophage-mediated resistance mechanisms against infection",
Toxicology, 93:269-297,1994; &M.M. Christensen et al, Institute of
Medical Microbiology, Comparison of interaction of meHgCl2 and
HgCl2 with murine macrophages, Arch Toxicol,
1993, 67(3):205-11;
(142) Ariza ME; Bijur GN; Williams MV. Lead and
mercury mutagenesis: role of H2O2, superoxide dismustase,
and xanthine oxidase. Environ Mol Mutagen
1998;31(4):352‑61; & M.E. Ariza et
al,
Mercury
mutagenesis, Biochem Mol Toxicol, 1999,
13(2):107-12;
(143) P.Boffetta et al, "Carciagenocity of mercury", Scand J Work Environ Health, 1993,19(1):1-7, &
Study of workers compensated for mercury intoxication, J Occup Med, 1994,36(11):1260-4; & J Occup Med, 36(11):1260-64, 1994;
(144) .Y Zaichick et al,
Trace Elements and thyroid cancer",Analyst,
120(3),1995.
(152) Langworth et al, Effects of low exposure to inorganic
mercury on the human immune system, Scand J Work Environ Health,
19(6): 405-413.1993;
(159) W.
Eggert-Kruse et al, Effect of heavy metals on in vitro interaction between
human sperm and cervical mucus, Dtsch Med Wochenschr , 1992, 117(37):1383-9(German); E.Ernst et al, Effect of mercury on human sperm
motility, Toxicol 1991,
68(6):440-4; & A.Daily et
al, Declining sperm count: evidence that Young�s
syndrome is associated with mercury, BMJ, 1996, 313(7048): 44;
(162) M.K.Mohamed et al, Effects of
methyl mercury on testicular functions in monkeys.Toxicol,
1987, 60(1):29-36;
& N.F. Ivanitskaia,
Evaluation of effect of mercury on reproductive function of animals,
Gig Sanit, 1991, 12: 48-51;
(180) Pinto
OF et al, J Intl Acad Prev Med, Vol 3,
No.2, 1976; & Huggins HA, Proposed
role of dental amalgam toxicity in leukemia and hemotopoietic dyscrasias. International
J of Biosocial and Medical Research, 1989, 11:84-93; & Schimpff SC, Young WH, Greene WH, Origin of infections
in acute nonlymphocytic leukemia. Annals of International
Medicine 1972, 77:707-711; & Y.Kinjo et al, Cancer mortality in patients exposed to
methyl mercury through fish diet, J Epidemiol, 1996, 6(3):134-8..
(181) P.W. Mathieson,
Mercury: god of TH2 cells,1995, Clinical Exp Immunol.,102(2):229-30
(193) E.N.Cohen et al, Occupational disease in dentistry,
Amer. Dent Assoc, 1980, 101(1): 21-31; & G. Bjorklund, Risk
evaluation of the occupational environment in dental care, Tidsski Nor Laegeforen,
1991, 111(8): 948-50; & A.Ahlbom et al,
:Dentists, dental nurses, and brain tumors, Br Med J, 1986,
202(6521):662.
(200) V.Nadarajah et al, Localized cellular inflammatory
response to subcutaneously implanted dental mercury, J Toxicol Environ Health, 1996,
49(2):113-25; Kulacz & Levy ,
"The Roots of Disease” Xlibris Corporation at 1-888-795-4274 www.xlibris.com;
& B.E. Haley, Dental Lab, www.altcorp.com
(201) Henningsson C,
Hoffmann S, McGonigle L, Winter JS. Acute mercury poisoning mimicking pheochromocytoma in
an adolescent. J Pediatr1993 Feb;122(2):252‑3
(206) R. Ma et al,
Association between dental restorations and carcinoma of the tongue, European
Journal of Cancer. Part B, Oral Oncology, 1995; 31B(4):
232-4.R; & P.34 Evaluation of premalignancy in oral lichenplanus and oral lichenoid lesions
using immunohistochemical expression of p53 and Ki67;
R.R. Acay,
S.C.O.M. Sousa and C.R. Felizzola; Oral Oncology
Supplement, Volume 1, Issue 1, 2005, Page 155; & Lichenoid dysplasia and malignant
transformation of oral lichen planus and oral lichenoid lesions;
P. Vescovi, M. Meleti, A. Ripasarti, et al;
Oral Oncology Supplement; Volume 2, Issue 1, Supplement 1, May 2007, Page 201
(222) M. Daunderer, Handbuch der Amalgamvergiftung, Ecomed Verlag, Landsberg 1998,
ISBN 3‑609‑71750‑5 (in German); & Improvement of Nerve and Immunological
Damages after Amalgam Removal, Amer. J. Of ProbioticDentistry and
Medicine, Jan 1991;
(225) S. Yannai et al, Transformations of inorganic mercury
by candida albicans ,
Applied Envir Microbiology,1991, 7:245-247;
& Ridley WP, Dizikes L, Cheh A, Wood JM. Recent studies
on biomethylation and demethylation of toxic elements.
Environ Health Perspect 1977 Aug;19:43‑6
(228) (a)A.F.Zamm,
Removal of dental mercury: often an effective treatment for very sensitive
patients, J Orthomolecular Med, 1990, 5(53):138-142. (22
patients), & (b)Dr. T. Rau, Paracelsus Alergy Clinic, Lustmuhle, Switzerland, Allergies: Causes,
Clarification, Treatment; Explore, 8(4),1996,
(232) H.A. Huggins
study funded by Adolph Coors Foundation, Denver, Study of blood chemistry
changes related to the presence or absence of amalgam in 30 patients,
(233)(a) Surviving
The Toxic Crisis by William R. Kellas ,
Andrea S. Dworkin , Comprehensive Health, 1996; &
(b) Histidin as a mercurial poisoning
inhibitor. Myshkin AE, Khromova VS. Biochem Biophys Res Commun. 2000
273(3):816-9;
(235) H.J.Hamre, Mercury from Dental
Amalgam and Chronic Fatigue Syndrome, The CFIDS Chronicle, Fall
1994, p44-47.
(237) H.D.
Foster, The calcium-selenium-mercury connection in cancer and heart disease,
Hypotheses, 1997, 48(4):335-60; & Whanger PD. Selenium
in the treatment of heavy metal poisoning and chemical
carcinogenesis. J Trace Elem Electrolytes Health Dis.
1992 Dec;6(4):209-21.
(239) J.M.Varga et al, High incidence of cross stimulation
by natural allergens of rat basophilic leukemia cells
sensitized with IgE antibodies, Int Arch
Allergy Immunol, 1995, 108(2):196-9; & J.H.Gainer,
Activation of Rauscher leukemia virus by metals, J Natl Cancer Inst,
1973, 51(2).609-13.
(251) (a) Y.Omura et al, Heart Disease Research Foundation,
NY,NY, Role of mercury in resistant infections and recovery after
Hg detox with cilantro, Acupuncture & Electro-Therapeutics
Research, 20(3):195-229, 1995; &(b) Mercury exposure from
silver fillings, Acupuncture & Electrotherapy Res, 1996, 133-
& The mercury connection to oral cancers, DAMS, www.flcv.com/olp.html
(256) D.B.Alymbaevaet al,
Med Tr Prom Ekol, 6:13-15, 1995
(Russian)
(260) J.S. Woods et
al, Urinary porphyrin profiles as biomarker of mercury
exposure: studies on dentists, J Toxicol
Environ Health, 40(2-3):1993, p235-; &
Altered porphyrin metabolites as a biomarker of mercury exposure and
toxicity, Physiol Pharmocol,
1996,74(2):210-15, & Canadian J Physiology and
Pharmacology, Feb 1996; & M.D.Martin et
al, Validity of urine samples for low-level mercury exposure
assessment and relationship
to porphyrin and creatinine excretion rates,
J Pharmacol Exp Ther,
Apr 1996;
(271) Alternative treatment of Multiple Schlerosis,
Tumor or Cancer, Institute for Naturopathic Medicine 1997 (40
cases
, http://home,t‑online.de/home/Institut_f._Naturheilverfahren/patinf.htm"
(283) A.Ahlbom et al, Dentists,
dental nurses, and brain
tumors, British Medical Journal, Vol292, March
8, 1986, p262.
(285) R.C. Perlingeiro et al, Polymorphonuclear phagentosis in
workers exposed to mercury vapor, Int J Immounopharmacology, 16(12):1011-7,1994; &
Hum Exp Toxicol 1995,
14(3):281-6;
(296) L.Bucio et al, Uptake,
cellular distribution and DNA damage produced by mercuric chloride in
a human fetal hepatic cell line. Mutat Res
1999 Jan 25;423(1‑2):65‑72; & (b) Ho PI, Ortiz D,
Rogers E, Shea TB. Multiple aspectsof homocysteine neurotoxicity:
glutamate excitotoxicity, kinase hyperactivation and DNAdamage.J Neurosci Res.
2002 Dec 1;70(5):694-702; &(c) Snyder RD; Lachmann PJ; Thiol involvement
in the inhibition of DNA repair by metals in mammalian cells. Source Mol Toxicol, 1989 Apr‑Jun,
2:2, 117‑28; & L.Verschaeve et al,
Comparative in vitro cytogenetic studies in mercury-exposed human
lymphocytes, Muta Res, 1985,
157(2-3):221-6; & L.Verschaeve,
Genetic damage induced by low level mercury exposure, EnvirRes,12:306-10,1976.
(328) P.
McKeever et al, Patterns of antigenic expression in
human glioma cells, Crit Rev Neurobiology, 1991, 6:119-147;
& Navas-Acien A, Pollan M, Gustavsson P,
Plato N. Occupation, exposure to chemicals and risk of gliomas and meningiomas in
Sweden. Am J Ind Med. 2002 Sep;42(3):214-27.
(330) (a) Wilkinson
LJ, Waring. Cysteine dioxygenase: modulation of expression in human cell lines
by cytokines and control of sulphate production. Toxicol In Vitro.
2002, Aug; 16(4): 481-3;; & (b) C.M. Tanner et al, Abnormal
Liver Enzyme Metabolism in Parkinsons,
Neurology, 1991, 41(5): Suppl 2, 89-92; & M.T.Heafield et al, “Plasma cysteine and
sulphate levels in patients with Motor neurone
disease, Parkinson's Disease, and Alzheimers Disease", Neurosci Lett, 1990, 110(1‑2), 216,20; & A.
Pean et al, "Pathways of cysteine metabolism in MND/ALS",
J neurol Sci, 1994, 124, Suppl:59‑61; & Steventon GB,
et al; Xenobiotic metabolism in motor neuron disease, The
Lancet, Sept 17 1988, p 644-47; & Neurology
1990, 40:1095-98.
(331) C. Gordon et al,
Abnormal sulphur oxidation in systemic
lupus erythrmatosus (SLE), Lancet, 1992,
339:8784,25-6; & P. Emory et al, Poor sulphoxidation in
patients with rheumatoid arthitis, Ann
Rheum Dis, 1992, 51:3,318-20; & Bradley H,
et al, Sulfate metabolism is abnormal in patients with
rheumatoid arthritis. Confirmation by in vivo biochemical
findings. J Rheumatol. 1994 Jul;
21(7): 1192-6; & T.L. Perry et al, Hallevorden-Spatz
Disease: cysteine accumulation and cysteine
dioxygenase deficiency, Ann Neural, 1985, 18(4):482-489.
(333) A.J. Freitas et al,
Effects of Hg2+ and CH3Hg+ on Ca2+ fluxes in the rat
brain, Brain Research, 1996, 738(2): 257-64; & P.R.Yallapragoda et al, Inhibition of
calcium transport by Hg salts in rat cerebellum and cerebral cortex,
J Appl toxicol, 1996, 164(4):
325-30; & E.Chavez et
al, Mitochondrial calcium release by
Hg+2",J Biol Chem, 1988, 263:8, 3582-;
(369) Sterzl I, Prochazkova J, Stejskal VDM et al, Mercury
and nickel allergy: risk factors in fatigue and
autoimmunity. Neuroendocrinology Letters 1999; 20:221-228; & Prochazkova J, Stejskal VD, et al; The beneficial effect of amalgam
replacement on health in patients with autoimmunity.
Neuro Endocrinol Lett. 2004 Jun;25(3):211-8. www.nel.edu/pdf_/25_3/NEL250304A07_Prochazkova_.pdf
(395) Baranski B.
Environmental Health Perspectives 1993; 101(suppl 2): 85-90;
& (b)Baranski B. Effect of mercury on the sexual cycle
and prenatal and postnatal development of progeny. Med Pr 1981; 32(4): 271-6; & (c) Hooper A,
Mercury poisoning in Dentistry, Wisconsin Medical J, Aug
1980, vol 79; & (d) Neurophysiological and
neuropsychological function in mercury-exposed dentists. The Lancet
1982; 1:1147-1150; Shapiro IM, et al; &(e) Chronic
low-level mercury exposure and neuropsychological functioning. J
of Clin and Exper Neuropsych 1986;
8:581-93; Uzzell BP and Oler J.
(403)
"An amalgam tattoo of the soft palate: a case report with energy
dispersive X-ray analysis. J Laryngol Otol, 1992 Sep, 106:9, 834-5; Mayall FG;
et al; & Pierson HF. "Pharmacological
perturbation of murine melanoma growth by copper chelates.
Cancer Lett, 1985 Mar, 26:2, 221-33.
(404)
Candida, Dysbiosis and Amalgam. J. Adv. Med. vol 9 no
2 (1996); M. E. Godfrey, & (b)
Immunity to
Candida Albicans: Th1, Th2 cells and beyond. Curr Opin Microbiol 1999,
2(4):363-7; Romani L, & Alfred V. Zamm. CANDIDA
ALBICANS THERAPY: Dental mercury removal, an effective adjunct. J. Orthmol. Med. v1#4 pp261-5 (1986)
(405) Stejskal J, Stejskal V. The
role of metals in autoimmune diseases and the link to neuroendocrinology Neuroendocrinology Letters, 20:345‑358, 1999.
www.melisa.org/knowledge/education14.html
(456) Panasiuk J, Peripheral blood lymphocyte transformation
test in various skin diseases of allergic origin. PrzeglDermatol
1980;67(6):823‑9 [Article in Polish] (nickel &
lupus)
(469) M.M.
van Benschoten, Acupoint Energetics of
Mercury Toxicity and Amalgam Removal with Case Studies, American Journal of
Acupuncture, Vol. 22, No. 3, 1994, pp.
251-262; & M.M. Van Benschoten and
Associates, Reseda, Calif. Clinic; http://www.mmvbs.com/
(486) Dr. Hulda Clark, The Cure for All Cancers,
1998, www.drclark.net; & Gerson Clinics,
www.gerson.org ; &
The End of Cancer, Nelson�s Books, 2003;
Charlotte Du Bois and John Lubecki, & Mercury detoxification, Healing Cancer Naturally, Dr. D. Klinghardt, http://www.klinghardtacademy.com; &
The Cancer Homepage, www.curezone.com/diseases/cancer/cancer_dental_risk.asp
(487) Dr. Hulda Clark, The Cure of HIV/AIDS, New
Century Press, 1993; &Dr. Hulda Clark, The Cure for All Diseases,
New Century Press, 2000,
(490) Prostate cancer, Ted Schettler, MD, Science Director, Science and Environmental Health
Network, and Chair, Science Work Group, CHE,
(491) DOH, Agency for Toxics
Substances and Disease Registry 1997; Waalkes 2000); & (c)
Prostate-specific antigen levels in relation to cadmium exposure and zinc
intake: results from the 2001-2002 National Health and Nutrition Examination
Survey. van WijngaardenE, Singer
EA, Palapattu GS. Prostate. 2008
Feb 1;68(2):122-8; & (d) Cadmium-induced cancers in animals and in
humans. Huff J, et al; Int J Occup Environ
Health. 2007 Apr-Jun;13(2):202-12; &(e) Trace elements and cancer
risk: a review of the epidemiologic evidence. Navarro Silvera SA, Rohan TE. Cancer Causes
Control. 2007 Feb;18(1):7-27
(492) Inorganic arsenic and human prostate cancer. Benbrahim-Tallaa L, Waalkes MP. Environ
Health Perspect. 2008 Feb;116(2):158-64
(493) Effects of metal ions, catechins, and their
interactions on prostate cancer. Yu HN, Shen SR, Yin JJ. Crit Rev
Food Sci Nutr. 2007; 47(8):711-9;
& (b)Inorganic arsenic and human prostate cancer. Benbrahim-Tallaa L, Waalkes MP. Environ Health Perspect.
2008 Feb;116(2):158-64
(494) (a) Cadmium-induced
cancers in animals and in humans. Huff J, et al. Int J Occup Environ Health. 2007 Apr-Jun;13(2):202-12, &
(b) Trace elements and cancer risk: a review of the epidemiologic
evidence. Navarro Silvera SA,
Rohan TE. Cancer Causes Control. 2007 Feb;18(1):7-27; &
(c) Prostate-specific antigen levels in relation to cadmium exposure and
zinc intake: results from the 2001-2002 National Health and Nutrition
Examination Survey. van Wijngaarden E, Singer
EA, Palapattu GS. Prostate. 2008
Feb 1;68(2):122-8.
(495) Soda drinkers have high pancreatic cancer risk, M. Pereira
et al, Cancer Epidemiology, Biomarkers & Prevention; Feb 2010.
Prolonged
ingestion of arsenic-containing drinking water is associated with an
increased risk of bladder cancer and skin cancer, and medical exposure to arsenic has
been clearly associated with skin cancer in epidemiological studies. In
addition, cancers of the lung, digestive
tract, liver, kidney, and lymphatic and hematopoietic systems have been linked to arsenic
exposure. ; & (c ) Arsenic Exposure and Risk of Urothelial
Cancer: Systematic Review and Meta-Analysis, Int J Environ Res
Public Health, 2020
Apr 29;17(9):3105.
[Arsenic
metabolites are significantly associated to urothelial cancer.]
Lung
cancer, Bladder cancer, Skin cancer, lung, digestive tract, liver, kidney, urothelial,
and lymphatic and hematopoietic systems
(497) The
Effects of Cadmium Toxicity, Int J Environ Res Public Health, 2020 May 26;17(11):3782.
(Epigenetic
changes and development of breast, lung, prostate, nasopharynx, pancreas, and
kidney cancers.)
& (b) Cadmium carcinogenesis, Mutat Res. 2003 Dec 10;533(1-2):107-20 (lung, prostate, renal) & (c)
Cadmium as a possible cause of bladder cancer: a review of accumulated
evidence, Envir Sci Pollut Res Int. 2014 Sep;21(18):10561-73; & (d) Cadmium
and renal cancer, Toxicol Appl Pharmacol.
2005 Sep 1;207(2):179-86.
(breast,lung,prostate,nasopharynx,pancreas, kidney,renel,bladder)
(498) Cancer
risk assessment for occupational exposure to chromium and nickel in welding
fumes from pipeline construction, pressure container manufacturing, and
shipyard building in Taiwan, J Occup Health,
2018 Nov 27;60(6):515-524. https://pubmed.ncbi.nlm.nih.gov/30122732/
(500) The mercury
connection to chronic health conditions, Review (B.Windham,
Ed.), http://www.myflcv.com/indexa.html, over 5,000 peer-reviewed
studies cited
(501) European Prospective Investigation into Cancer and Nutrition
(EPIC), American Journal of Clinical Nutrition.87(4):985-92
; & NutraIngredients.com April 9, 2008
(503) Effects of metal ions, catechins, and their
interactions on prostate cancer. Yu H, Yin JJ. Crit Rev
Food Sci Nutr. 2007;47(8):711-9.
(504) Banerjee S, Manna S, Saha P, Panda CK, Das S. Black tea polyphenols
suppress cell proliferation and induce apoptosis
during benzo(a)pyrene-induced lung cancer. Eur J Cancer
Prev. 2005, 14(3):215-21; & Banerjee S, Manna
S, Mukherjee S, et al, Black tea polyphenols restrict benzopyrene-induced
mouse lung cancer progression through inhabitation of Cox-2 and induction of
caspase-3 expression. Asian Pac J Cancer Prev.
2006, 7(4):661-6; & Banerjee S, Maity P, Mukherjee S
et al, Black tea prevents cigarette smoke-induced apoptosis and lung damage,
J Inflamm (Lond.)
2007: 43.
(505) Beltz LA, Bayer DK, Moss AL, Simet IM. Mechanisms of cancer prevention by
green tea and black tea polyphenols. Anticancer Agents, Med
Chem. 2006, 6(5):389-406; & Kalra N,
Set K, Prasad S, et al, Theaflavins induced apoptosis
of LNCaP cells is mediated through induction of p53, down-regulation
of NF-kappa B and mitogen-activated
protein kinases pathways. Life Sci 2007 16:80(23):2137-46; & Park AM, Dong
Z. Signal transduction pathways: targets for green and black
tea polyphenols. J Biochem Mol Biol.
2003 Jan 31:36(1):66-77.
(506) Life Extension, Disease Prevention and
Treatment, Fifth Edition, 2013; & Life
Extension Disease Prevention and Treatment Book, 6th Edition; & (b) Life Extension Magazine, www.lifeextension.com &
Life Extension Magazine, Jan 2009,July
2018, etc.
(530) Cancer case
histories followed by doctors, www.whale.to/d/cancer.html
(531) Integrative Medicine and the
Role of Modified Citrus Pectin/Alginates in Heavy MetIntegrative Medicine
and the Role of Modified Citrus Pectin/Alginates in Heavy
Metal Chelation and Detoxification, Five Case Reports; Eliaz, I., Wilk, B. ; Forsch Komplementrmed 2007;14:358-364
http://content.karger.com/ProdukteDB/produkte.asp?Aktion=JournalFreeSample&ProduktNr=224242
(539) A cascade analysis of the interaction of mercury
and coproporphyrinogen oxidase (CPOX) polymorphism on
the heme biosynthetic pathway
and porphyrin production. Heyer NJ, Bittner
AC, Echeverria D, Woods JS. Toxicol Lett.
2006 Feb 20;161(2):159-66. Epub 2005 Oct 7.
(543) U.S. Centers for Disease
Control, National Center for
Health Statistics, NHANES III study(thousands of people�s health monitored), http://www.myflcv.com/NHanes3.html
& http://www.mercola.com/article/mercury/no_mercury.htm
(546) Rob Edwards
and Duncan Graham-Rowe. "Electrical
connection" New Scientist 6 March 2002;
& Dr. Mae-Wan Ho, National Radiological Protection Board (NRPB),
Electromagnetic Fields Double Leukemia Risks 2002; & Richard Doll et al,
Cancer Studies Unit, Oxford Univ., March 2002; & London SJ; Bowman
JD; Sobel E; Thomas DC; GarabrantDH;
Pearce N; Bernstein L; Peters JM. Exposure to magnetic fields among
electrical workers in relation to leukemia risk in Los
Angeles County. Am J Ind Med 1994 Jul;26(1):47-60;
& Caplan LS; Schoenfeld ER; O'Leary ES; Leske MC. Breast cancer and electromagnetic fields--a
review. Ann Epidemiol 2000 Jan;10(1):31-44;
(547) Environmental Cancer Risk: What We Can Do
Now." President�s Cancer Panel Report,
2008-2009Dr. LaSalle Leffall et al, US National Institutes of
Health. National cancer Institute. Division of Extramural Activities
/Suzanne H. Reuben for the President�s Cancer Panel
(550) J.
S. Malpas, M.D., Treatment Options for Multiple Myeloma, New England
Journal of Medicine, December 12th, 2002; & Riccardi et
al, British Journal of Cancer 2000;82:1254-60.
(551) Cancer
Treatment, Dr. T. Simoncini, http://www.curenaturalicancro.com/
(552) International
Medical Veritas Assoc., & http://www.winningcancer.com/ &
Dr. Mark Sircus, http://www.magnesiumforlife.com/ & http://www.beating-cancer-gently.com/nl118.html
& Iodine Treatment, http://phaelosopher.wordpress.com/2007/08/01/an-mind-opening-discussion-on-iodine-with-dr-mark-sircus-podcast/
(553) Budwig Flax Oil &
Cottage Cheese Cancer Treatment,
http://www.cancertutor.com/Cancer/Budwig.html & http://www.cancure.org/budwig_diet.htm
(560) Outsmart
Your Cancer: Alternative Non-Toxic Treatments that Work, Tanya Pierce,
MFCC, 2009
(570) Reversing
Cancer: A Journey from Cancer to Cure, Dr. Gerald H. Smith, ICNR, 2006
(571) Of metalicized mouths, mycotoxicosis,
and oxygen, Townsend Letter for Doctors and Patients, June, 2005 by Philip Mollica, Robert Harris www.findarticles.com/p/articles/mi_m0ISW/is_263/ai_n13784466/pg_1
(572) Dietary
Supplementation with Chlorella pyrenoidosa Produces
Positive Results in Patients with Cancer or Suffering from Certain Common
Chronic Illnesses, R.E. Merchant and C.A. Andre, Townsend Letter for Doctors
& Patients, Feb/Mar 2001; & Amalgam Detox, Klinghardt Academy of
Neurobiology, 2008
(580) Cancer as a Fungal
Disease, Tullio Simoncini,
MS, www.cancerisafungus.com/
(581) The Prime Cause and
Prevention of Cancer (1969)--Dr Otto
Warburg (Nobel prize winner)
(582) Rising Ocean Temperatures, Toxic Metal Pollution Have
Oysters In Hot Water, American Physiological Society, Comparative
Physiology 2006, www.sciencedaily.com/releases/2006/10/061012185131.htm
Case #3: A 51
year-old male presented with
stage four squamous cell carcinoma located in the right pharyngeal-tonsil
space. EG underwent conventional therapy with little to no success. Clinical
exam revealed cavitational osteonecroticlesion in
the area of the lower right third molar. Soft tissue exam revealed swollen and
inflamed pharyngeal arches, bilateral tonsilar inflammation
and enlargement. Extraoral palpation revealed minor swelling of
lymphatic nodes on the right side. Treatment goal was not to treat the cancer
but to eradicate the infective state in the head and neck. EG was placed on
a 3- month head and neck oxygen/ozone protocol developed by Dr. Mollica. This protocol was inclusive of direct and indirect
infusion of 21 micograms/cc of oxygen/ozone into
the afflicted areas. The afflicted areas being the osteonecrotic lesions, soft tissues, and lymphatic
tissue. In addition to the oxygen/ozone therapy nutritional and drainage
support was provided. Within a month after the completion of the protocol EG
was given an exam which included a PET scan. No trace of the cancer or any
activity associated with the lesion was found. Attributed to spontaneous
remission.
(I witnessed 2 very similar “cures”
while being treated for cavitation problems by Dentist in West Palm Beach,
Florida-B.Windham)